Raj Rajagovindan

Raj Rajagovindan is an accomplished professional in the field of clinical development and biomedical engineering, currently serving as Vice President of Clinical Development Sciences at Vigil Neuroscience since November 2021. Prior experience includes roles as Director of Biomarkers at Biogen from October 2016 to November 2021, and Senior Scientist III at AbbVie from January 2013 to September 2016. Additional positions held are Senior Scientist II at Abbott and Research Scientist at Orasi Medical. Raj Rajagovindan earned both a Master of Science and a Doctorate in Biomedical Engineering from the University of Florida, completing studies from 2004 to 2009.